
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
BioIVT announced that it has joined the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium. They join a public-private biomedical research partnership that brings together members of academia, industry, patient advocacy organizations, and government agencies to develop and support research.
Read the full release






